Avid Bioservices IncNASDAQ:CDMO
- LAST PRICE12.3200
- TODAY'S CHANGE (%)0.0200 (0.1626%)
- Bid / Lots12.3100/ 85
- Ask / Lots12.3200/ 6
- Open / Previous Close12.2800 / 12.3000
- Day Range
- 52 Week Range
- Volume425,007
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CDMO |
|---|---|---|
| 09:32 ET | 25114 | 12.3 |
| 09:33 ET | 24887 | 12.3 |
| 09:35 ET | 200 | 12.3 |
| 09:37 ET | 5617 | 12.3 |
| 09:39 ET | 2167 | 12.3 |
| 09:42 ET | 2974 | 12.3 |
| 09:44 ET | 5174 | 12.3 |
| 09:46 ET | 1400 | 12.305 |
| 09:48 ET | 17871 | 12.305 |
| 09:50 ET | 1799 | 12.31 |
| 09:51 ET | 600 | 12.3 |
| 09:53 ET | 200 | 12.305 |
| 09:55 ET | 1625 | 12.31 |
| 09:57 ET | 100 | 12.305 |
| 10:00 ET | 300 | 12.3 |
| 10:02 ET | 902 | 12.31 |
| 10:04 ET | 300 | 12.3 |
| 10:08 ET | 200 | 12.3 |
| 10:09 ET | 100 | 12.305 |
| 10:11 ET | 1500 | 12.305 |
| 10:13 ET | 559 | 12.3 |
| 10:15 ET | 100 | 12.305 |
| 10:18 ET | 1243 | 12.3 |
| 10:20 ET | 11912 | 12.3 |
| 10:22 ET | 1408 | 12.3081 |
| 10:24 ET | 1240 | 12.3 |
| 10:26 ET | 1200 | 12.3 |
| 10:27 ET | 1013 | 12.305 |
| 10:29 ET | 1229 | 12.305 |
| 10:31 ET | 590 | 12.3 |
| 10:33 ET | 1137 | 12.3 |
| 10:36 ET | 799 | 12.3 |
| 10:38 ET | 1341 | 12.305 |
| 10:40 ET | 2588 | 12.305 |
| 10:42 ET | 900 | 12.3 |
| 10:44 ET | 2530 | 12.3 |
| 10:45 ET | 1607 | 12.3 |
| 10:47 ET | 7974 | 12.31 |
| 10:49 ET | 546 | 12.305 |
| 10:51 ET | 1280 | 12.3 |
| 10:54 ET | 700 | 12.31 |
| 10:56 ET | 2380 | 12.3 |
| 10:58 ET | 500 | 12.305 |
| 11:00 ET | 400 | 12.305 |
| 11:02 ET | 600 | 12.305 |
| 11:03 ET | 300 | 12.305 |
| 11:05 ET | 1000 | 12.305 |
| 11:07 ET | 553 | 12.3 |
| 11:09 ET | 1652 | 12.31 |
| 11:12 ET | 3894 | 12.3 |
| 11:14 ET | 1436 | 12.3 |
| 11:16 ET | 100 | 12.305 |
| 11:18 ET | 669 | 12.305 |
| 11:20 ET | 1168 | 12.31 |
| 11:21 ET | 700 | 12.305 |
| 11:23 ET | 1700 | 12.305 |
| 11:25 ET | 1146 | 12.31 |
| 11:27 ET | 600 | 12.305 |
| 11:30 ET | 200 | 12.305 |
| 11:32 ET | 2616 | 12.305 |
| 11:34 ET | 200 | 12.305 |
| 11:36 ET | 3800 | 12.31 |
| 11:38 ET | 1000 | 12.31 |
| 11:39 ET | 2035 | 12.31 |
| 11:41 ET | 1000 | 12.305 |
| 11:43 ET | 1376 | 12.31 |
| 11:45 ET | 800 | 12.305 |
| 11:48 ET | 1899 | 12.305 |
| 11:50 ET | 900 | 12.305 |
| 11:52 ET | 1500 | 12.305 |
| 11:54 ET | 500 | 12.305 |
| 11:56 ET | 900 | 12.31 |
| 11:57 ET | 300 | 12.305 |
| 11:59 ET | 900 | 12.305 |
| 12:01 ET | 500 | 12.31 |
| 12:03 ET | 500 | 12.305 |
| 12:06 ET | 2000 | 12.305 |
| 12:08 ET | 2046 | 12.305 |
| 12:10 ET | 600 | 12.305 |
| 12:12 ET | 800 | 12.305 |
| 12:14 ET | 500 | 12.305 |
| 12:15 ET | 698 | 12.305 |
| 12:17 ET | 200 | 12.305 |
| 12:19 ET | 400 | 12.305 |
| 12:21 ET | 200 | 12.305 |
| 12:24 ET | 800 | 12.305 |
| 12:26 ET | 500 | 12.305 |
| 12:28 ET | 200 | 12.305 |
| 12:30 ET | 300 | 12.305 |
| 12:32 ET | 700 | 12.305 |
| 12:33 ET | 100 | 12.305 |
| 12:35 ET | 800 | 12.305 |
| 12:37 ET | 100 | 12.305 |
| 12:39 ET | 300 | 12.305 |
| 12:42 ET | 3363 | 12.305 |
| 12:44 ET | 2000 | 12.31 |
| 12:46 ET | 802 | 12.31 |
| 12:48 ET | 500 | 12.305 |
| 12:50 ET | 3820 | 12.305 |
| 12:51 ET | 800 | 12.305 |
| 12:53 ET | 500 | 12.305 |
| 12:55 ET | 100 | 12.305 |
| 12:57 ET | 6496 | 12.31 |
| 01:00 ET | 900 | 12.305 |
| 01:02 ET | 37645 | 12.305 |
| 01:04 ET | 53816 | 12.325 |
| 01:06 ET | 300 | 12.33 |
| 01:08 ET | 2270 | 12.32 |
| 01:09 ET | 9354 | 12.315 |
| 01:11 ET | 3450 | 12.315 |
| 01:13 ET | 5947 | 12.32 |
| 01:15 ET | 1164 | 12.32 |
| 01:18 ET | 2100 | 12.315 |
| 01:20 ET | 2814 | 12.315 |
| 01:22 ET | 5600 | 12.315 |
| 01:24 ET | 3902 | 12.32 |
| 01:26 ET | 1013 | 12.32 |
| 01:27 ET | 5267 | 12.315 |
| 01:29 ET | 2800 | 12.32 |
| 01:31 ET | 1716 | 12.32 |
| 01:33 ET | 3987 | 12.32 |
| 01:36 ET | 1842 | 12.32 |
| 01:38 ET | 7019 | 12.32 |
| 01:40 ET | 6364 | 12.315 |
| 01:42 ET | 2323 | 12.32 |
| 01:44 ET | 5844 | 12.32 |
| 01:45 ET | 2316 | 12.32 |
| 01:47 ET | 504 | 12.32 |
Nov 21, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AE, CDMO, ALTR on Behalf of Shareholders, from 10:04AM ET on Thursday Nov 21, 2024 by Dow Jones
10:04AM ET on Thursday Nov 21, 2024 by Dow JonesKuehn Law Encourages AVAV, AE, CDMO, and ALTR Investors to Contact Law Firm, from 9:03AM ET on Thursday Nov 21, 2024 by Dow Jones
9:03AM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 16, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AE, ROIC, CDMO, EMKR on Behalf of Shareholders, from 11:31AM ET on Saturday Nov 16, 2024 by Dow Jones
11:31AM ET on Saturday Nov 16, 2024 by Dow Jones
Nov 15, 2024
Lifshitz Law PLLC Announces Investigations of ALVR, EMKR, CDMO, and ROIC, from 9:46PM ET on Friday Nov 15, 2024 by Dow Jones
9:46PM ET on Friday Nov 15, 2024 by Dow Jones
Nov 14, 2024
*DJ Punch and Associates Sends Letter to Bd of Directors of Avid Bioservices, Inc., from 5:48PM ET on Thursday Nov 14, 2024 by Dow Jones
5:48PM ET on Thursday Nov 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Avid Bioservices Inc | 786.7M | -5.4x | --- |
Entrada Therapeutics Inc | 703.5M | 12.2x | --- |
Adaptive Biotechnologies Corp | 692.1M | -4.4x | --- |
Prothena Corporation PLC | 785.6M | -6.4x | --- |
Gyre Therapeutics Inc | 1.1B | -53.4x | --- |
Kamada Ltd | 337.5M | 18.8x | -22.48% |
Company Information
Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization (CDMO) focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biologics. The Company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the Company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of its services ranges from standalone process development projects to full development and manufacturing programs through commercialization. Commercial biologics produced by it are distributed to over 90 countries.
Contact Information
- Headquarters
- 14191 MYFORD ROADTUSTIN, CA, United States 92780
- Phone
- 714-508-6100
- Fax
- 714-838-5817
Executives
- Independent Chairman of the Board
- Joseph Carleone
- President, Chief Executive Officer, Director
- Nicholas Green
- Chief Financial Officer
- Daniel Hart
- Chief Operations Officer
- Richard Richieri
- Vice President, General Counsel
- Mark Ziebell
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $786.7M |
|---|---|
Revenue (TTM) | $142.4M |
Shares Outstanding | 64.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.44 |
EPS | $-2.27 |
Book Value | $0.96 |
P/E Ratio | -5.4x |
Price/Sales (TTM) | 5.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -14.66% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
